This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Treatment of Inhalant Abuse With Risperidone

Lalith K. Misra, Lial Kofoed, and William Fuller

Published: September 30, 1999

Article Abstract

Letter to the Editor

Sir: Because inhalants are inexpensive, readily available, and easily concealed, they are frequently the first mood-altering substances used by children. Surveys reveal inhalant use as early as 6 years of age, increasing to a rate of 21.6% in 8th grade. Acute effects of inhalants include euphoria, spatial and visual distortions, and impulsivity. Chronic use leads to neurologic and psychiatric symptoms including incoordination, irritability, paranoia, aggression, and cognitive impairments.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 60

Quick Links: Dementia , Neurologic and Neurocognitive

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...